semaglutide nash Inching Closer to a Cure: Daily Achieves Resolution of NASH but Not Fibrosis after 72 Weeks Semaglutide Improves Histology in MASH:

Furthermore, treatment with a GLP-1 receptor agonist reduced the risk of death from any cause and risk of hospital admission for heart failure

18c) 36

The MC4 receptor and control of appetite

But some users do report mild side effects, including: Headaches or dizziness (typically at higher doses or when stacking with GH-related peptides) Injection site irritation , redness, or swelling Nausea or GI discomfort when taken orally (more common with low-quality forms) Changes in mood or energy , including restlessness or mild anxiety These symptoms are usually temporary and resolve quickly with dosage adjustment or cycling off